Japanese startup Elix is using AI to research COVID-19 drugs

The global search for a COVID-19 vaccine and treatment is on. Researchers are using every resource at their disposal to try and find a breakthrough against the killer virus. That includes artificial intelligence (AI). The tech has previously shown promise as a tool for drug development, but now researchers are putting it to the ultimate test -- finding a drug that treats COVID-19 in record time. A Japanese startup called Elix is leading the charge thanks to deep learning software from Nvidia. Finding drug molecules to treat diseases used to be a task that took years.